Welcome to Prevenar 13®

Prevenar 13® (Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)) is indicated for:1

  • Active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants and children from 6 weeks to 17 years of age.  
  • Active immunisation for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae in adults ≥18 years of age and the elderly.

The use of Prevenar 13® should be determined on the basis of official recommendations taking into consideration the risk of invasive disease and pneumonia in different age groups, underlying comorbidities as well as the variability of serotype epidemiology in different geographical areas.1

References

  1. Prevenar 13® Summary of Product Characteristics. Available here

 

Prescribing Information
Prevenar 13® prescribing information.

 

< Back to Vaccines Hub

 

PP-PNA-GBR-0415.  June 2020